EDNRB and uveal melanoma: Remarkably, in uveal melanoma cells it has been demonstrated that also the ETBR acts as an upstream activator of YAP signaling, representing a therapeutic escape pathway from MEK inhibitors, one of the most explored targeted therapies for uveal melanoma [94].